ScienceDaily (Aug. 16, 2010) — A study led by a researcher at Albert Einstein College of Medicine of Yeshiva University has revealed a unique “partnership” between two types of bone marrow stem cells, which could lead to advances in regenerative medicine. The study was led by Paul Frenette, M.D., the new director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Einstein. Dr. Frenette conducted the research while at Mt. Sinai School of Medicine in New York City. The research was published in the Aug 12 issue of Nature.
adaptive immunity Alzheimer's Disease antibiotics apoptosis autism Breast cancer C. elegans Caenorhabditis elegans cancer chromatin circadian clocks CRISPR cryo-electron microscopy DNA dopamine Drosophila Epigenetics eukaryotes evolution gene expression Genomics histones HIV HIV AIDS human genome immunity metabolism microRNA miRNA mitochondria mRNA neural circuits neurodegeneration neurons obesity optogenetics Parkinson's Disease pathogenesis proteomics ribosomes RNA stem cells synapses transcription vaccines